Calix: Looming Growth Points To 40% Upside

Lester Goh profile picture
Lester Goh
861 Followers

Summary

  • Investors have capitulated on Calix as the Company continued to disappoint in recent quarters.
  • The market is skeptical with respect to the likelihood of continued sales growth as well as the moderation of expense growth going forward.
  • Commentary from Dycom, who is one step before CALX in the value chain, suggests that sales growth is not a mirage.
  • Relative to close peer Adtran, Calix’s current OpEx levels should be able to support revenue significantly higher (possibly 70% higher) than current levels.
  • Shares see ~40% upside, without accounting for the value of ~$674m in federal/state NOLs. Downside is protected by an already-pessimistic market perception and a large discount to Adtran.

Following the winding down of government broadband stimulus mandated by the American Recovery and Reinvestment Act of 2009 which led to a slowdown in sales growth (~16% in '13, ~5% in '14, ~1.6% in '15), Calix (NYSE:NYSE:CALX) ("Calix", "CALX", or "the Company") has sorely disappointed longs in recent quarters. Management has remained firm on their stance that a sustained and pronounced reinvigoration in top-line growth is just around the corner, but their statements appear to be falling on deaf ears.

Post-3Q '15, shares fell 24% on soft 4Q guidance which suggested the possibility of customers delaying capital spending, which undoubtedly worried investors. While 4Q saw strong FCC CAF II orders, quarterly revenues declined ~6% y/y, suggesting that consistent growth was still elusive, resulting in shares selling off ~14%. The sharp sell-offs can be seen below.

Source: Finbox.io

1Q '16 was uneventful, save for management guiding 2Q '16 sales to be between $104m and $108m, which at the mid-point suggests ~7% y/y growth, highlighting that the Company's growth trajectory would be much stronger going forward. Executives also implied that OpEx should moderate once the Occam litigation is over - which should be around 3Q '16; the Company filed with the SEC on April 18 showing that it had signed a memorandum of understanding regarding the litigation settlement.

However, like the story of the boy who cried wolf, investors are not buying it; shares have hardly moved since the 1Q '16 report. It is clear that the market is skeptical about two things: 1) the likelihood of continued sales growth, and 2) the moderation of OpEx going forward. More broadly, investors are still undecided over whether the Company can ever be profitable - as seen below, despite growing revenue in recent years, EBITDA and net income are still going in the wrong direction.

This article was written by

Lester Goh profile picture
861 Followers
College freshman based in Singapore looking to break into the buy/sell-side. Grateful for opportunities to interview locally.Blog: https://wondurrrrboy.wordpress.com/Disclaimer: The author's reports contain factual statements and opinions. He derives factual statements from sources which he believes are accurate, but neither they nor the author represent that the facts presented are accurate or complete. Opinions are those of the the author and are subject to change without notice. His reports are for informational purposes only and do not offer securities or solicit the offer of securities of any company. Mr. Goh ("Lester") accepts no liability whatsoever for any direct or consequential loss or damage arising from any use of his reports or their content. Lester advises readers to conduct their own due diligence before investing in any companies covered by him. He does not know of each individual's investment objectives, risk appetite, and time horizon. His reports do not constitute as investment advice and are meant for general public consumption. Past performance is not indicative of future performance.

Analyst’s Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Disclaimer: The author's reports contain factual statements and opinions. He derives factual statements from sources which he believes are accurate, but neither they nor the author represent that the facts presented are accurate or complete. Opinions are those of the the author and are subject to change without notice. His reports are for informational purposes only and do not offer securities or solicit the offer of securities of any company. Mr. Goh ("Lester") accepts no liability whatsoever for any direct or consequential loss or damage arising from any use of his reports or their content. Lester advises readers to conduct their own due diligence before investing in any companies covered by him. He does not know of each individual's investment objectives, risk appetite, and time horizon. His reports do not constitute as investment advice and are meant for general public consumption. Past performance is not indicative of future performance.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About CALX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

More on CALX

Related Stocks

SymbolLast Price% Chg
CALX
--